Trial Profile
Phase 2 study of pretreatment with hydroxyurea prior to induction therapy for patients with newly diagnosed acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2019
Price :
$35
*
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Acute myeloid leukaemia; Leucopenia
- Focus Therapeutic Use
- Acronyms PREFACE
- 31 May 2019 Status changed from recruiting to completed.
- 29 Nov 2013 New trial record